Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19217556 | 1.00 | ALDH1A1 (0.66) | ALDH1A1CYP3A4 | |
| SCHEMBL19215771 | 1.00 | ALDH1A1 (0.66) | ALDH1A1CYP3A4 | |
| SCHEMBL10013736 | 0.82 | ALDH1A1 (0.66) | ALDH1A1CYP3A4 | |
| SCHEMBL23604784 | 0.81 | ALDH1A1 (0.64) | ALDH1A1CYP3A4 | |
| SCHEMBL23604782 | 0.81 | ALDH1A1 (0.64) | ALDH1A1CYP3A4 | |
| SCHEMBL2821152 | 0.79 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL6836764 | 0.79 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL30393565 | 0.79 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL28910450 | 0.79 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL15846 | 0.79 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4401801-A | Coating and dressing agents for leather and leather substitutes based on polyurethane urea coating compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1983-08-30 | — | — | US | claimed |
| EP-2821429-B1 | Siloxane polymers with central polysiloxane polymer block with urea and/or carbamate groups and amino acid residues with terminal organofunctional residues | EVONIK DEGUSSA GMBH (DE) | 2017-03-22 | — | — | EP | disclosed |
| US-20150004113-A1 | SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH TERMINAL ORGANOFUNCTIONAL RADICALS COMPRISING UREA AND/OR CARBAMATE GROUPS AND AMINO ACID RADICALS | EVONIK DEGUSSA GMBH (DE) | 2015-01-01 | — | — | US | disclosed |
| US-20150004112-A1 | SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH ORGANOFUNCTIONAL RADICALS EACH HAVING AT LEAST TWO BIVALENT GROUPS SELECTED FROM UREA AND/OR CARBAMATE GROUPS AND AT LEAST ONE UV/VIS CHROMOPHORE AS RADICAL | EVONIK INDUSTRIES AG (DE) | 2015-01-01 | — | — | US | disclosed |
| WO-2009155291-A1 | CURABLE COMPOSITIONS CONTAINING URETHANE LINKAGES FOR REWORKABLE ADHESIVES | HENKEL CORPORATION (US) | 2009-12-23 | — | — | WO | disclosed |
| WO-2007021762-A2 | METHODS AND MATERIALS FOR FABRICATING MICROFLUIDIC DEVICES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2007-02-22 | — | — | WO | disclosed |
| EP-0996655-B1 | THIXOTROPIC TWO-COMPONENT POLYURETHANE SYSTEMS | SIKA GMBH (DE) | 2003-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150004112-A1 | SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH ORGANOFUNCTIONAL RADICALS EACH HAVING AT LEAST TWO BIVALENT GROUPS SELECTED FROM UREA AND/OR CARBAMATE GROUPS AND AT LEAST ONE UV/VIS CHROMOPHORE AS RADICAL | CCNI, UBE2I, CCNB1 | ALDH1A1 2209/4885CYP3A4 1031/4885 |
| US-20150004113-A1 | SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH TERMINAL ORGANOFUNCTIONAL RADICALS COMPRISING UREA AND/OR CARBAMATE GROUPS AND AMINO ACID RADICALS | UBE2I, CCNI, IL4I1 | ALDH1A1 3526/4885CYP3A4 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.